Plante Moran Financial Advisors, LLC Concert Pharmaceuticals, Inc. Transaction History

Plante Moran Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$12.82 - $17.88 $19,230 - $26,820	-1,500 Closed	0 $0
Q2 2018 Jul 26, 2018	BUY	$16.83 - $21.66 $25,244 - $32,490	1,500 New	1,500 $25,000
Q1 2018 May 01, 2018	SELL	$19.24 - $28.03 $38,480 - $56,060	-2,000 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$13.96 - $29.05 $13,960 - $29,050	1,000 Added 100.0%	2,000 $52,000
Q3 2017 Nov 08, 2017	BUY	$13.91 - $15.31 $13,910 - $15,310	1,000	1,000 $15,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.